Introducing the 2018 DPAC Patient Advisory Board!

DPAC is proud to announce the

2018 Patient Advisory Board!

The members of the inaugural PAB will act as trusted spokespeople in all of DPAC’s advocacy efforts, promote DPAC’s mission within their communities, share their policy training skills, and […]

Transparency in Diabetes Drug Pricing

What is transparency in diabetes drug pricing?

The word “transparency” gets tossed around a lot by people in the healthcare community (it was even one of DPAC’s top 5 buzzwords from a drug supply chain Congressional Health Subcommittee hearing in December).  When patients […]

Medicaid Work Requirements Will Prevent People from Receiving Care

Medicaid Work Requirements Will Prevent People from Receiving Care

In January, the Centers for Medicare and Medicaid Services (CMS) issued a guidance which announced that states would be allowed to require work hours for certain people on Medicaid. This is a huge departure from what CMS has said before, […]

Top 5 Takeaways from the White House Report on Drug Pricing

Top 5 Takeaways from the White House White Paper on Drug Pricing

On February 9th, the White House released a white paper on the causes and potential solutions to high drug prices. There are several important takeaways from the report, and we’ve compiled the top 5 for you here (just […]

How Closed Formularies Hurt Patients

How Closed Formularies Hurt Patients

Insurance providers have a problem: how do they balance the cost of drugs to patients versus the cost of drugs to themselves? Drug costs can pile up quickly on either side of the scale (or both!). To try and find the balance, many

How the FDA Drug Approval Process Works

The FDA Drug Approval Process

The FDA Center for Drug Evaluation and Research (CDER) is the watchdog for potential medications seeking approval for use in the United States. In order for CDER to begin evaluating a drug, pharmaceutical companies must first do […]

Are You A Passionate Diabetes Advocate? Join the DPAC Patient Advisory Board!

DPAC Patient Advisory Board

A picture of a diverse group of people smiling.

After this year’s tumultuous ride in diabetes policy advocacy, you may feel like we need a break.

Nope. This is when we mobilize – and we need you. […]

Drug Importation Isn’t The Long-Term Solution

 Drug Importation Isn’t The Long-Term Solution

Though drug importation may seem like a logical solution to a very real drug pricing problem, importing drugs from Canada or other foreign sources is not good for individual consumers or the American economy. There are two main reasons:

  • There is currently […]

Big Win for Diabetes Medicare Beneficiaries & Thank You!

Big Win for Diabetes Medicare Beneficiaries & Thank You!

group of people crowded together to make a man flexing musclesOn February 9, 2018, the President signed the Bipartisan Budget Act of 2018, which included a big win for our diabetes Medicare community […]

Affordable Insulin Project Helps People Advocate!

The new year brings some wonderful things: renewed optimism for the future, resolutions that may or may not be abandoned by February, and plans for a year that seems full of potential. But the dreaded deductible reset also accompanies the new year for many people. Paying for […]